Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -43.234% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCC1Oc2ccc(C)cc2N(CC(=O)NC2CCCCC2)C1=O
b CCCOc1cccc(C(=O)Nc2ccccc2C(=O)N2CCN(C)CC2)c1
c CN(C)C(=O)C[n+]1ccc(C(N)=O)cc1.[Cl-]
Answer: b. CCCOc1cccc(C(=O)Nc2ccccc2C(=O)N2CCN(C)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOc1cccc(C(=O)Nc2ccccc2C(=O)N2CCN(C)CC2)c1
CCCOc1cccc(C(=O)Nc2ccccc2C(=O)N2CCN(C)CC2)c1
N-[2-(4-methylpiperazine-1-carbonyl)phenyl]-3-propoxybenzamide